Author

Cristina Fornaguera

Institució Catalana de Recerca i Estudis AvançatsORCID 0000-0002-7014-3213Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 2 Research Focus:drug response / drug discovery· 2 Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:multiome· 1 Approach:statistical model· 1

Frequent Co-Authors

Anna López‐PlanaiD· 1 shared Chiara CannatáiD· 1 shared Coral García-FernándeziD· 1 shared Elena Haro-MartíneziD· 1 shared Gabriel Serra-MiriD· 1 shared José Ángel Palomeque· 1 shared Marc SabartésiD· 1 shared María Sanz‐FloresiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anna López‐PlanaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Targeting dendritic cells with RNA-loaded nanoparticles grafted with short peptides

Vladimir Stamenkovic, Mislav Brajkovic, Coral García-Fernández, Salvador Borrós, Xevi Biarnés, Cristina Fornaguera

This paper designs and evaluates RNA-loaded nanoparticles conjugated with short peptides to selectively target dendritic cells via Clec9A, improving immunotherapeutic selectivity and efficacy.

bioRxiv · Nov 5, 2025 · PreprintBioengineering

Reconfiguration of tumor cells with LCOR transcription factor mRNA nanotherapy to enhance immunotherapy efficacy

Gabriel Serra-Mir, Elena Haro-Martínez, Chiara Cannatá, José Ángel Palomeque, Sandra Blasco-Benito, Anna López‐Plana, María Sanz‐Flores, Marc Sabartés, Cristina Fornaguera, Toni Celià-Terrassa

This paper develops an mRNA nanotherapy using LCOR to enhance immunotherapy in breast cancer by restoring antigen presentation and reducing tumor growth.

bioRxiv · Apr 2, 2025 · PreprintCancer Biology